Investing.com - Varian reported on Monday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Varian announced earnings per share of $0.85 on revenue of $794.5M. Analysts polled by Investing.com anticipated EPS of $0.93 on revenue of $778.94M. That with comparison to EPS of $1.05 on revenue of $779.4M in the same period a year before.Varian had reported EPS of $1.16 on revenue of $828.9M in the previous quarter.Analysts are expecting EPS of $0.8 and revenue of $659.28M in the upcoming quarter.
Varian shares are down 19% from the beginning of the year and are trading at $116.50 , down-from-52-week-high.They are under-performing the S&P 500 which is down 12.39% year to date.
Varian shares gained 1.86% in after-hours trade the report.
Varian follows other major Healthcare sector earnings this month
Varian's report follows an earnings beat by J&J on Tuesday, April 14, 2020, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Pfizer had beat expectations on Tuesday, April 28, 2020 with first quarter EPS of $0.8 on revenue of $12.03B, compared to forecast for EPS of $0.73 on revenue of $11.81B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar